Pakistan Updates Pharmacovigilance Guidance To Factor In New Rules
Revised guidelines on pharmacovigilance follow newly introduced legislation on this front.
You may also be interested in...
A new guidance document explains how Pakistan’s revamped pharmacovigilance system will work.
Investigational products from Minoryx and a host of other companies targeting a range of diseases are now under review by the European Medicines Agency for potential EU approval.
The sponsors of Alsitek and quizartinib are hoping that new data generated for the drugs will resolve the concerns raised by the European Medicines Agency when it previously rejected the products for marketing in the EU.